AAAAAA
Results:
1-17
|
Results: 17
Authors:
ZAFRANI ES
VANNHIEU JT
GERMANIDIS G
MAVIER P
Citation: Es. Zafrani et al., AUTOIMMUNE CHOLANGIOPATHIES, Gastroenterologie clinique et biologique, 22(1), 1998, pp. 43-49
Authors:
DUVOUX C
TRAN NA
INTRATOR L
GERMANIDIS G
PAWLOTSKY JM
CHERQUI D
DHUMEAUX D
Citation: C. Duvoux et al., MIXED CRYOGLOBULINEMIA AFTER LIVER-TRANSPLANTATION FOR HCV CIRRHOSIS, Hepatology, 28(4), 1998, pp. 388-388
Authors:
HEZODE C
DUVOUX C
GERMANIDIS G
ROUDOTTHORAVAL F
CHERQUI D
PAWLOTSKY JM
DHUMEAUX D
Citation: C. Hezode et al., HCV INFECTION AND POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD)AFTER LIVER-TRANSPLANTATION (LT), Hepatology, 28(4), 1998, pp. 389-389
Authors:
PAWLOTSKY JM
DAHARI H
CONRAD A
LOAJON I
HEZODE C
GERMANIDIS G
SCHMID P
DHUMEAUX D
NEUMANN AU
Citation: Jm. Pawlotsky et al., EFFECT OF INTERMITTENT INTERFERON (IFN), DAILY IFN AND IFN PLUS RIBAVIRIN INDUCTION THERAPY ON HEPATITIS-C VIRUS (HCV) GENOTYPE 1B REPLICATION KINETICS AND CLEARANCE, Hepatology, 28(4), 1998, pp. 502-502
Authors:
CASTERA L
GERMANIDIS G
FRAINAIS PO
HEZODE C
DHUMEAUX D
PAWLOTSKY JM
Citation: L. Castera et al., EARLY CHANGES IN HCV HYPERVARIABLE REGION-1 (HVR1) AND NON STRUCTURAL(NS) 5A GENE QUASI-SPECIES DURING INTERFERON (IFN)-ALPHA OR RIBAVIRINTREATMENT - CLUES TO THE MECHANISMS OF HCV RESISTANCE TO ANTIVIRAL THERAPY, Hepatology, 28(4), 1998, pp. 503-503
Authors:
PAWLOTSKY JM
GERMANIDIS G
FRAINAIS PO
BOUVIER M
DHUMEAUX D
Citation: Jm. Pawlotsky et al., GENETIC-CHARACTERIZATION OF HYPERVARIABLE REGION-1 (HVR1) QUASI-SPECIES CHANGES DURING INTERFERON (IFN)-ALPHA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 28(4), 1998, pp. 505-505
Authors:
GERMANIDIS G
HAIOUN C
POURQUIER J
REYES F
DHUMEAUX D
PAWLOTSKY JM
Citation: G. Germanidis et al., ROLE OF HEPATITIS-C VIRUS IN OVERT B-CELL NON-HODGKIN-LYMPHOMA IN FRANCE, Hepatology, 28(4), 1998, pp. 1603-1603
Authors:
PAWLOTSKY JM
PELLERIN M
BOUVIER M
ROUDOTTHORAVAL F
GERMANIDIS G
BASTIE A
DARTHUY F
REMIRE J
SOUSSY CJ
DHUMEAUX D
Citation: Jm. Pawlotsky et al., GENETIC COMPLEXITY OF THE HYPERVARIABLE-REGION-1 (HVR1) OF HEPATITIS-C VIRUS (HCV) - INFLUENCE ON THE CHARACTERISTICS OF THE INFECTION AND RESPONSES TO INTERFERON-ALPHA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C, Journal of medical virology, 54(4), 1998, pp. 256-264
Authors:
PAWLOTSKY JM
ROUDOTTHORAVAL F
MUERHOFF AS
PELLERIN M
GERMANIDIS G
DESAI SM
BASTIE A
DARTHUY F
REMIRE J
ZAFRANI ES
SOUSSY CJ
MUSHAHWAR IK
DHUMEAUX D
Citation: Jm. Pawlotsky et al., GB-VIRUS-C (GBV-C) INFECTION IN PATIENTS WITH CHRONIC HEPATITIS-C - INFLUENCE ON LIVER-DISEASE AND ON HEPATITIS-VIRUS BEHAVIOR - EFFECT OF INTERFERON-ALFA THERAPY, Journal of medical virology, 54(1), 1998, pp. 26-37
Authors:
PAWLOTSKY JM
GERMANIDIS G
NEUMANN AU
PELLERIN M
FRAINAIS PO
DHUMEAUX D
Citation: Jm. Pawlotsky et al., INTERFERON RESISTANCE OF HEPATITIS-C VIRUS GENOTYPE 1B - RELATIONSHIPTO NONSTRUCTURAL 5A GENE QUASI-SPECIES MUTATIONS, Journal of virology, 72(4), 1998, pp. 2795-2805
Authors:
PAWLOTSKY JM
GERMANIDIS G
PELLERIN M
FRAINAIS PO
SOUSSY CJ
DHUMEAUX D
Citation: Jm. Pawlotsky et al., DO HEPATITIS-C VIRUS NS5A GENE-SEQUENCES DETERMINE SENSITIVITY TO INTERFERON-ALFA - A QUASI-SPECIES STUDY, Hepatology, 26(4), 1997, pp. 711-711
Authors:
PAWLOTSKY JM
BOUVIER M
BASTIE A
LEFRERE JJ
DACOSTA I
GERMANIDIS G
PELLERIN M
ZAFRANI ES
DHUMEAUX D
Citation: Jm. Pawlotsky et al., WHAT IS THE REAL EFFECT OF INTERFERON-ALFA ON HEPATITIS-C VIRUS-REPLICATION AND QUASI-SPECIES AND THE LIVER IN PATIENTS WITH CHRONIC HEPATITIS-C, Hepatology, 26(4), 1997, pp. 955-955
Authors:
PAWLOTSKY JM
GERMANIDIS G
HURAUX C
NAUDIN G
HARVEY T
ESTRANGIN E
DESAI S
MUERHOFF AS
BASTIE A
REMIRE J
DARTHUY F
MUSHAHWAR I
DUVAL J
DHUMEAUX D
ROUDOTTHORAVAL F
Citation: Jm. Pawlotsky et al., MOTHER-TO-INFANT TRANSMISSION OF GB VIRUS-C (GBV-C) AND HCV IN HCV-INFECTED PREGNANT-WOMEN, Hepatology, 24(4), 1996, pp. 396-396
Authors:
PAWLOTSKY JM
ROUDOTTHORAVAL F
PELLERIN M
GERMANIDIS G
DESAI S
MUERHOFF AS
BASTIE A
DARTHUY F
REMIRE J
ZAFRANI ES
MUSHAHWAR I
DUVAL J
DHUMEAUX D
Citation: Jm. Pawlotsky et al., GBV-C INFECTION IN HCV-INFECTED PATIENTS - EPIDEMIOLOGIC CHARACTERISTICS, INFLUENCE ON HCV INFECTION AND RESPONSE TO INTERFERON-ALFA THERAPY, Hepatology, 24(4), 1996, pp. 397-397
Authors:
GERMANIDIS G
PELLERIN M
BASTIE A
STUYVER L
DUVERLIE G
DARTHUY F
REMIRE J
DUVAL J
DHUMEAUX D
PAWLOTSKY JM
Citation: G. Germanidis et al., STUDY OF THE GENETIC-HETEROGENEITY OF THE NS5A REGION OF THE HCV-1B GENOME AND EVOLUTION UNDER INTERFERON-ALFA THERAPY, Hepatology, 24(4), 1996, pp. 551-551
Authors:
SERFATY L
PAWLOTSKY JM
GERMANIDIS G
CHAZOUILLERES O
PILON A
POUPON R
Citation: L. Serfaty et al., IS GB-VIRUS-C (GBV-C) THE CAUSE OF CRYPTOGENETIC CHRONIC LIVER-DISEASE, Hepatology, 24(4), 1996, pp. 1802-1802
Authors:
MITLIANGA P
GERMANIDIS G
MOUTSOPOULOS HM
PAPADOPOULOS GK
Citation: P. Mitlianga et al., THE EFFECT OF TRANSFORMING GROWTH-FACTOR-BETA-1, AND TUMOR-NECROSIS-FACTOR-ALPHA ON THE CYTOTOXIC-CYTOSTATIC ACTION OF INTERLEUKIN-1 (ALPHA-ISOFORMS AND BETA-ISOFORMS) ON THE PANCREATIC B-CELL LINE RIN-5AH, International journal of immunopathology and pharmacology, 8(2), 1995, pp. 67-77
Risultati:
1-17
|